Page 301 - FINAL PROGRAMME 2017

P-678 Circulating irisin and GIP, but not asprosin, underscore the manifestation of polycystic ovary syndrome
T.H. Chin1, S.Y. Huang1, Y.C. Hsu1, Y.K. Soong1, C.L. Chang1 1Chang Gung Memorial Hospital, OB/GYN, Taoyuan, Taiwan R.O.C.
P-679 Agonist trigger is associated with defective progesterone production and decreased LH receptor and VEGF expression in luteal granulosa cells that are partially reversed by hCG
N. Akin1, G. Bildik1, A. Seyhan2, B. Balaban2, B. Urman2,3, O. Oktem2,3
1Koc University School of Medicine- Graduate School of Health Sciences, Reproductive Biology, Istanbul, Turkey
2American Hospital, Women's Health Center- Assisted Reproduction Unit, Istanbul, Turkey
3Koc University School of Medicine, Department of Obstetrics and Gynecology - the division of reproductive endocrinology and infertility, Istanbul, Turkey
P-680 The usage of Daphaston and hMG protocol in normalovulatory women undergoing controlled ovarian hyperstimulation during IVF/ICSI treatments in combination with embryo cryopreservation
X. Zhu1, H. Ye2, Y. Fu1
1Shanghai Ninth People’s Hospital, Department of Assisted Reproduction, Shanghai, China 2Shanghai Ninth People’s Hospital, Department of Assisted Reproduction-, Shanghai, China
P-681 Ontogeny of newly described hypo-androgenic PCOS phenotype in infertile women from younger through older ages
D. Albertini1, V. Kushnir2,3, S. Darmon2, Q. Wang2, L. Zhang2, D. Barad2,4, N. Gleicher2,4,5,6 1The Center for Human Reproduction, New York- NY, U.S.A.
2Center for Human Reproduction, n/a, New York- NY, U.S.A.
3Wake Forest School of Medicine, Obstetrics & Gynecology, New York- NY, U.S.A. 4Foundation for Reproductive Medicine, n/a, New York- NY, U.S.A.
5Medical University Vienna, Obstetrics & Gynecology, Vienna, Austria
6Rockefeller University, Stem Cell and Molecular Embryology Laboratory, New York- NY, U.S.A.
P-682 Inositol treatment of anovulation in women with polycystic ovary syndrome: a meta-analysis of randomised trials
J. Pundir1, D. Psaroudakis2, P. Savnur2, P. Bhide3, L. Sabatini2, H. Teede4, A. Coomarasamy5, K. Khan6, S. Thangaratinam6
1St Bartholomew's Hospital, Centre of Reproductive Medicine, London, United Kingdom
2St. Bartholomew’s Hospital, Centre for Reproductive Medicine, London, United Kingdom
3Homerton University Hospital, Fertility and Assisted Reproduction, London, United Kingdom
4Monash University, Monash Centre for Health Research and Implementation, Melbourne, Australia
5University of Birmingham, Tommy’s National Centre for Miscarriage Research, Birmingham, United Kingdom
6Barts and The London School of Medicine and Dentistry, Women's Health Research Unit, London, United Kingdom
FINAL PROGRAMME I GENEVA, SWITZERLAND – 2 TO 5 JULY 2017 301
POSTERS